NGL Fine-Chem Limited (NSE:NGLFINE) filed a corrigendum on 20 August 2026 to its 45th Annual Report for the financial year 2025-26, disclosing that certain CSR figures on page 26 were incorrectly labelled as "Crores" when they should have read "Lakhs," with the company confirming no impact on audited financial statements.
Key Highlights
- The corrigendum corrects a typographical error on page 26 of the FY26 Annual Report, under the Corporate Social Responsibility section, where "Crores" appeared instead of "Lakhs."
- The corrected figures show FY26 CSR spend as Rs 41.50 Lakhs and the statutory CSR obligation as Rs 51.61 Lakhs, replacing the erroneously stated Crore denominations.
- The company confirmed the error is confined to the non-statutory portion of the Annual Report and has no bearing on the audited financial statements for the year ended 31 March 2026.
- The 45th Annual General Meeting of NGL Fine-Chem is scheduled for 25 August 2026 at 11:00 AM IST, to be held via Video Conferencing and Other Audio-Visual Means.
About the Company
NGL Fine-Chem Limited (NSE:NGLFINE) is a Mumbai-headquartered pharmaceutical and specialty chemicals manufacturer engaged primarily in the production of Active Pharmaceutical Ingredients (APIs) and veterinary APIs. The company operates manufacturing facilities and serves both domestic and international markets, with its shares listed on the National Stock Exchange of India and BSE under scrip code 524774.
Announcement in Detail
NGL Fine-Chem Limited filed the corrigendum with BSE and NSE on 20 August 2026, referencing its earlier communication of 31 July 2026 through which the Annual Report and AGM Notice for FY2025-26 were circulated to shareholders. The filing identifies a specific typographical error in the non-statutory section of the report, on page 26 under the Corporate Social Responsibility heading, where units of measurement for two CSR figures were incorrectly stated.
The corrected disclosure establishes the company's actual FY26 CSR spend at Rs 41.50 Lakhs and its statutory CSR obligation at Rs 51.61 Lakhs for the same year. The company's Company Secretary and Compliance Officer, Shivam Gharat (Membership No. A56704), signed and submitted the corrigendum. An updated version of the Annual Report incorporating these corrections has been made available on the company's official corporate website for shareholder reference ahead of the 25 August 2026 AGM.
Impact on Investors
Investors will note that the corrigendum does not alter any figures within the audited financial statements for the year ended 31 March 2026. The filing explicitly states that the error was confined to the non-statutory narrative portion of the Annual Report, meaning reported revenues, profits, and balance sheet items remain unchanged. Shareholders reviewing the CSR section of the original Annual Report should replace the figures marked in Crores with the corrected Lakhs denominations as specified.
The disclosed terms indicate that the statutory CSR obligation for FY26 stood at Rs 51.61 Lakhs, against an actual spend of Rs 41.50 Lakhs. Shareholders will observe that the corrected Annual Report is the operative document and should be read in conjunction with this corrigendum when assessing the company's CSR compliance position for FY2025-26.
Sector / Market Context
India's pharmaceutical and specialty chemicals sector operates under comprehensive disclosure and compliance requirements governed by SEBI's Listing Obligations and Disclosure Requirements Regulations. Companies listed on Indian exchanges are required to ensure accuracy in all communications to shareholders, including annual reports. The Ministry of Corporate Affairs mandates CSR spending disclosures in annual reports under the Companies Act, 2013, making the accurate representation of CSR figures a regulatory compliance matter. Corrigendum filings of this nature, addressing non-statutory narrative errors, are a standard mechanism through which listed companies maintain the integrity of shareholder communications without restating their audited accounts.